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Prevention of hemodialysis fistula thrombosis. Early detection of
venous stenoses. Venous dialysis pressures were measured consecu-
tively in 168 chronic hemodialysis patients for 265 patient-years of
monitored dialysis. Venous dialysis pressure > 150 mm Hg measured
by the protocol were considered elevated. Seventy-three patients had
elevated venous dialysis pressures and 58 agreed to undergo elective
venography (fistulogram). Fifty of 58 patients studied (86%) had signif-
icant venous stenoses. A combination of percutaneous transluminal
angioplasty (PTA) and surgical revision were used to electively treat
these stenoses. Early detection and treatment of these stenoses de-
creased fistula thrombosis and fistula replacement threefold compared
with our earlier experiences. Patients with elevated venous dialysis
pressure who were venogramed and treated had an occurrence of fistula
thrombosis similar to patients with normal dialysis pressure (0.15 and
0.13 episodes per patient year of dialysis respectively, P = NS). In
contrast patients with elevated venous dialysis pressure who refused
elective fistulogram and treatment averaged 1.4 episodes of thrombosis
per patient year of dialysis (P < 0.001 compared to both other groups).
We conclude that elevated venous dialysis pressure is a reliable method
of detecting fistula stenoses and that the elective treatment of these
stenoses significantly decreases fistula thrombosis and fistula loss.
Vascular access for hemodialysis patients is provided by the
use of endogenous (native) or synthetic arteriovenous fistulas.
Maintaining patent vascular access is a major problem espe-
cially in an ageing hemodialysis population with limited vascu-
lar access sites [1—4]. The most common cause of fistula failure
is thrombosis, usually caused by venous stasis associated with
venous stenotic lesions [I]. These venous stenoses have typi-
cally been detected following fistula thrombosis and have been
treated by surgical revision [1—4]. To our knowledge, a system-
atic approach that involves the early detection and treatment of
venous stenoses before thrombosis has not been previously
described. We noted previously that high venous dialysis pres-
sure occurred in a high proportion of patients with subsequently
detected venous stenoses [5, 6]. We therefore designed this
study to focus on elevated venous dialysis pressure as a means
of detecting venous stenoses prior to fistula thrombosis. We
arrived at our current criteria for elevated pressure by retro-
spective analysis of the data in our first study [5]. This report
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summarizes our experience with a method for the elective
identification and early treatment of venous stenoses associated
with hemodialysis fistulas.
Methods
Patients
Chronic hemodialysis patients treated at the Duke University
dialysis units were monitored for venous dialysis pressure at
each hemodialysis treatment from April, 1986 through Novem-
ber, 1988 (32 months). This reflects 265 patient years of moni-
tored hemodialysis therapy. No hemodialysis patients were
excluded from the monitoring procedures in this study. Venous
dialysis pressures were measured with a mechanical electrical
strain gauge and read from the venous pressure monitor of a
Gambro AK-b or similar hemodialysis machine (Gambro, Inc.,
Lincolnshire, Illinois, USA). Venous dialysis pressures were
measured at extracorporeal blood flows of 200 to 225 mI/mm
through 16 gauge needles for the first 30 minutes of each
treatment before increasing to maximum blood flow. Under
these conditions venous dialysis pressure greater than 150 mm
Hg consistently present during three consecutive hemodialysis
treatments was considered abnormal. Patients with elevated
venous dialysis pressure underwent outpatient venography of
the fistula (fistulogram) extended to include the entire subcla-
vian vein. If discreet venous stenoses were detected (>50%
reduction of the lumen) percutaneous transluminal angioplasty
(PTA) was usually performed as the initial therapeutic ap-
proach. Lesions longer than six centimeters were referred for
elective surgical revision as previously described [5, 6]. PTA
was usually performed as an outpatient procedure (96% of the
cases) immediately after fistulogram. Patients were dialyzed in
the hospital dialysis unit after angioplasty before being dis-
missed.
The method for angioplasty of hemodialysis fistulas and
proximal veins has been previously described [5, 6]. Angio-
plasty catheters were inserted either into the fistula or the vein
proximal to the fistula 62%, the femoral vein 32%, or some
combination of the above 6% and were fluoroscopically guided
to the stenotic lesion. Contrast studies were obtained post-PTA
to document flow across dilated stenoses. Treatment was
considered technically successful if the stenosis was reduced
>50%. Hemostasis was obtained at the end of the procedure by
15 to 20 minutes of manual compression.
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Surgical revision and thrombectomy of fistulas were per-
formed by one of three vascular surgeons. All surgical revisions
were performed as an inpatient procedure. Thrombectomy was
routinely performed as an outpatient procedure.
The protocol for measurement of venous dialysis pressure
was developed by analysis of venous pressure in our earlier
study [5]. Variability in venous pressure caused by needle
placement led to the requirement for elevated pressure on three
consecutive treatments. Faster blood flows showed erratic
fluctuations in venous pressures, forcing us to standardize
pressure measurements at 200 to 225 mI/minute. The entire
hemodialysis population was monitored for the occurrence of
venous thrombosis, results of thrombectomy, surgical revi-
sions, and replacement of vascular access grafts. Data for the
pre-study control period (1985 to 1986) were obtained retro-
spectively by chart review and from hemodialysis quality
assurance reports and operating room files. Data were analyzed
with analysis of variance for continuous data and with chi
square for categorical data. Data are reported as means
standard errors.
Results
Elevated venous dialysis pressures were detected in 73
patients (mean age 52 11 years; 36 males, 37 females).
Vascular access in these 73 patients included synthetic fistulas
(65) in the forearm (27), upper arm (37), or axilla (1) in both loop
(40), and straight (25), configuration. Native fistulas (8) were all
in the forearm position. Fifty-eight of 73 patients underwent
diagnostic fistulograms; fifteen patients refused (Fig. I).
Of those patients studied, 50 of 58 (86%) had 62 discrete
stenoses (Fig. 1). Thirty-four (54%) of these lesions occurred at
the vein-fistula anastomosis and 28 (46%) occurred in the
proximal vein. All 34 vein-fistula stenotic lesions underwent
PTA (Fig. 1). Twenty-eight vein-fistula lesions (82%) underwent
successful transluminal angioplasty (Fig. 1). Six of these 34
(18%) were not technically successful (determined by contrast
study) and were electively referred for surgical revision. Twen-
ty-eight stenoses were proximal venous lesions. Thirteen of
these occurred in the subclavian vein and all underwent trans-
luminal angioplasty. There were no technical failures in those
patients with subclavian lesions. Fifteen stenoses were in the
proximal venous system other than the subclavian vein. Seven
of these 15 (46%) had poor venous maturation with diffuse
lesions and were referred for elective surgical revision (Fig. 1).
Five of eight patients with elevated venous pressure who
were venogramed and did not have a detectable stenosis
ultimately normalized their venous dialysis pressures without
intervention. Three of eight patients maintained elevated
venous dialysis pressure and one subsequently developed a
thrombosis.
Fifteen patients (mean age 46 8 years, 8 males, 7 females)
with elevated dialysis pressure refused fistulograms (Figs. 1, 2).
Thirteen of these 15 (86%; Fig. 2) developed an episode of
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Fig. 1. Treatment selection process for
patients with elevated venous hemodialysis
pressure.
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Fig. 3. Diagnostic fistulogram showing a stenosis in a proximal vein. The white arrow indicates the location of the stenosis before (A) and after
(B) PTA.
thrombosis during the study. Twelve of these 15 patients (80%)
had a significant venous stenoses. In six patients the thrombus
could not be surgically removed, resulting in placement of a
new vascular access graft. The clinical course of these 15
patients is described in Figure 2.
One hundred and forty-three patients maintained normal
venous dialysis pressure for all or a part of this study. Fourteen
randomly-selected patients (mean age 54 6 years; 7 males, 7
females) with normal dialysis pressure underwent fistulogram.
Only one of these patients (7%) had a venous stenosis. These 14
patients are comparable to the entire hemodialysis population
with normal dialysis pressure. They are similar in age, time on
dialysis, incidence of diabetes, and occurrence of peripheral
vascular disease. Based on the assumption that these 14 pa-
tients are similar to the dialysis population with normal dialysis
pressure a calculated specificity of elevated venous dialysis
pressure for detection of venous stenosis is 93% with a sensi-
tivity of 86%. Additional normal patients were not venogramed
because of the cost involved with little likelihood of detecting a
treatable lesion.
Of those 34 vein fistula stenoses that underwent successful
PTA (Fig. I), four (12%) recurred after a mean follow-up time of
13 months post-procedure. Of the eight proximal venous sten-
oses that underwent PTA (Fig. 1), there have been two recur-
rences (25%; mean follow-up time 15 months). Four of 13 (30%)
of the subclavian stenoses have recurred after a mean 12
months of follow-up. There have been no recurrences in the 13
lesions treated with surgical revision after a mean of 12 months.
In all episodes, the recurrence of the vascular lesion was
heralded by elevated venous dialysis pressure. Repeat angio-
plasty was performed on 9 of 10 patients with technical success.
Figure 3 shows the results of PTA in an example of proximal
venous stenoses. PTA of a vein fistula stenosis [5] and of a
central vein stenosis [61 has been previously shown.
Table 1 examines the occurrence of thrombosis in the treat-
ment group and both control groups: 1.) elevated venous
pressure, no fistulogram; 2.) normal dialysis pressure. These
groups of patients were similar in age, sex, race, and occur-
rence of diabetes and peripheral vascular disease. The fre-
quency of thrombosis per patient year of dialysis was lowest in
Table 1. Fistula thrombosis rates
Elevated dialysis pressures
NormalNo
Fistulogram fistulogram dialysis pressures
Thrombosis 12 17 23
episodes
Patient years of 81 12 172
dialysis
Thromboses per 0.15 1.4 0.13
patient year
the group of patients with normal venous dialysis pressure
(0.13) and was not statistically different from those patients with
elevated dialysis pressure who underwent fistulogram and elec-
tive treatment (0.15; P = NS; Table 1). In contrast, those
patients with elevated dialysis pressure who refused fistulogram
had a higher occurrence of thrombosis per patient year of
dialysis than the other patient groups (1.4; P <
.001; Table 1).
Figure 4 depicts venous dialysis pressure by patient group.
Mean venous dialysis pressure in the total patient population
(mean of 5 separate measurements in the hemodialysis popula-
tion) was 108 12 mm Hg. Mean dialysis pressure in the 14
patients with normal pressure who underwent fistulogram was
109 7 mm Hg. In the 15 patients with elevated dialysis
pressure who refused elective fistulogram (Fig. 2) mean pres-
sure was 203 19 mm Hg (Fig. 4). Of the 58 patients who
underwent elective fistulogram (Fig. I) mean pressure was 199
19 mm Hg (Fig. 4). In these 58 patients there were no
differences in mean dialysis pressure regardless of whether a
stenosis was (201 20 mm Hg; N = 50) or was not (174 17
mm Hg; N = 8) found. Following treatment (PTA or surgery)
dialysis pressure fell significantly to 110 9 mm Hg (P < .001;
Fig. 4).
Before the start of this study (1985 to 1986) there were 52
episodes of vascular access thrombosis with 22 vascular access
replacements in our patient population (Table 2). During the
study (April, 1986 through November, 1988) only 52 episodes of
fistula thrombosis and 19 fistula replacements occurred (Table
2). Thus, the incidence of fistula thrombosis per patient year on
100 200 300
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Post-treatment; all patients
with elevated VDP and stenosis
Replace-
Patient Episodes Thromboses ment per
years of of throm- per patient Fistulas patient
dialysis bosis year replaced year
l985_l986a 85.3 52 0.61 22 0.26
12 months
1987_1988b 265 52 0.20 19 0.07
32 months
dialysis was 0.61 (61%) in 1985 to 1986, before the development
of the technique described here, and fell to 0.20 (20%) during
the study (Table 2). In addition the fistula replacement rate has
decreased from 0.26 (26%) to 0.07 (7%) as a result of these
techniques (Table 2). There were no changes in surgical tech-
nique, surgeons performing these procedures, or synthetic
fistula material during the control or study period.
Three complications occurred during this study that required
hospitalization. One patient developed an episode of prolonged
angina and one patient developed a large femoral hematoma.
Contrast extravasation occurred in one instance. There were no
other complications associated with the procedure. Specifically
there were no episodes of fistula rupture, contrast allergy, or
loss of the vascular access patency associated with these
procedures.
Discussion
Providing satisfactory vascular access for hemodialysis re-
mains one of the most challenging problems confronting ne-
phrologists. Synthetic fistulas are now the most common type
of vascular access as it becomes more difficult to find satisfac-
Fig. 4. Venous dialysis pressures in various
subgroups of hemodialysis patients. *p = NS,
= NS, ***p < .001
tory veins to form a new native fistula as older patients enter
dialysis [1—5]. Synthetic fistula survival at one year has varied
with two year survival of approximately 50% [1—4]. Stenotic
lesions in the venous limb are the most common anatomic cause
of thrombosis in both synthetic and native hemodialysis fistulas
[1]. The usual method of restoring patency is by surgical
thrombectomy of clotted hemodialysis fistulas and surgical
revision of stenotic lesions [1—4]. Surgical revision has the
major drawback of extending vascular access grafts further up
the extremity, thereby, minimizing sites for future placement of
vascular access. In addition, surgical therapy of stenotic lesions
in the axillary and subclavian veins is technically difficult. We
and others have reported preliminary results with percutaneous
transluminal angioplasty as a method of treating venous steno-
ses [5—Il].
The early detection of venous stenoses is the essential first
step in preventing fistula thrombosis. Elevated venous dialysis
pressure serves as an excellent means of electively detecting
these stenoses (Fig. 1). Using the venous dialysis pressure
protocol as outlined 86% of the patients with elevated dialysis
pressure had venous stenosis (Fig. 1). In contrast only 7% of
venogramed patients with normal dialysis pressure had a
venous stenosis. Thus the calculated specificity of elevated
venous dialysis pressures in detecting venous stenoses is 93%
and the calculated sensitivity is 86%. Treatment of venous
stenoses decreased dialysis pressures to normal (Fig. 4). If
stenoses recurred elevated venous dialysis pressures were
again detectable. These observations show that venous steno-
ses can be reliably detected by the use of elevated venous
dialysis pressures. Thus, the number of fistulograms can be
limited to those patients with a high likelihood of venous
stenoses.
Undetected venous stenoses were associated with a higher
rate of fistula thrombosis. Patients with elevated venous dialy-
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Table 2. Thrombosis and fistula replacement
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sis pressure who refused elective evaluation and treatment had
a high rate of fistula thrombosis and fIstula replacement (Fig. 2).
This high rate of thrombosis cannot be explained by differences
in patient age, sex, race, peripheral vascular disease, or time on
maintenance dialysis therapy. It is best explained by the fact
that 12 of 15 patients in this group had venous stenoses that
went untreated (Fig. 2).
Table 1 depicts the episodes of fistula thrombosis as a
function of venous dialysis pressure. Patients with normal
venous dialysis pressure had the lowest thrombosis rate (0.13
episodes per patient year of dialysis). Patients with elevated
dialysis pressure who refused elective evaluation and treatment
had a significantly greater occurrence of thrombosis (1.4 epi-
sodes per patient year of dialysis) reflecting untreated venous
stenosis. In contrast patients with elevated venous pressure
who underwent elective evaluation and treatment of their
venous stenoses had an occurrence of thrombosis that was
significantly lower than patients with elevated pressure who
refused evaluation (P < .001) and was not different than
patients with normal pressure (P = NS; Table 1).
Thrombosis in a hemodialysis fistula can occur for a variety
of reasons. Volume depletion, hypotension and external com-
pression are three commonly cited causes of venous thrombosis
that can occur independently of significant venous or arterial
stenoses. The occurrence of fistula thrombosis in patients
without stenosis is apparent from our data (Figs. 1, 2, Table 1).
Nonetheless our results show that the elective identification and
treatment of stenoses can significantly decrease the thrombosis
rate for hemodialysis fistulas (Table 2). Since the institution of
these strategies, the incidence of thrombosis and fistula replace-
ment per patient year on hemodialysis decreased more than
threefold compared with data from our center prior to use of
these methods (Table 2). Stenoses treated with PTA have a
higher recurrence rate than stenoses treated with surgical
intervention. However, multiple PTA procedures are possible
in a given fistula and upon a single stenosis thereby prolonging
the life of the original fistula without extending the fistula
further up the arm.
In conclusion, measurement of venous dialysis pressures
when used in conjunction with fistulography, angioplasty, and
surgical revision provides a strategy for reducing the incidence
of thrombosis and fistula replacement.
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